 acquir cisplatin resist human ovarian cancer cell enhanc repair cisplatin-dna lesion reduc drug accumul studi resist human ovarian cancer cell cell line respect characterist drug accumul efflux cytosol inactiv drug dna repair experi drug exposur cell line resist cell respect dose drug accumul rate similar cell line resist cell line effici drug reduc total drug accumul equival micromolar drug exposur equival level total cellular drug accumul cell line level cisplatin-dna damag cytosol inactiv drug differenti resist cell line resist cell effici cisplatin-dna lesion cellular dna transfect plasmid dna cell line alter drug uptake/efflux dna repair major factor resist